Meth-OD: A Phase 2a Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
Latest Information Update: 20 Nov 2023
At a glance
- Drugs IXT-m200 (Primary) ; Haloperidol; Lorazepam
- Indications Substance-related disorders
- Focus Adverse reactions
- Acronyms Meth-OD
- Sponsors InterveXion Therapeutics
- 05 Jan 2023 Status changed from recruiting to discontinued.
- 07 Dec 2022 Planned End Date changed from 30 Sep 2022 to 31 Dec 2022.
- 07 Dec 2022 Planned primary completion date changed from 31 Aug 2022 to 31 Dec 2022.